| ASSET | DATE | % RETURN |
|---|---|---|
Trio Petroleum (TPET) | 2/1/2024 | 46.34% |
Ostin Technology (OST) | 2/1/2024 | 45.89% |
Firefly Neuroscience (AIFF) | 2/1/2024 | 39.59% |
MetaVia (MTVA) | 2/1/2024 | 38.13% |
Akso Health Group ADR (AHG) | 2/1/2024 | 35.67% |
Strive (ASST) | 2/1/2024 | 33.62% |
Atara Biotherapeutics (ATRA) | 2/1/2024 | 32.8% |
Azio AI (AZIO) | 2/1/2024 | 28% |
Kyntra Bio (KYNB) | 2/1/2024 | 26.74% |
Enveric Biosciences (ENVB) | 2/1/2024 | 25.47% |
Roadzen (RDZN) | 2/1/2024 | 25.37% |
PepGen (PEPG) | 2/1/2024 | 23.41% |
BioRestorative Therapies (BRTX) | 2/1/2024 | 22.73% |
Sangrix (SGRX) | 2/1/2024 | 21.91% |
Pixelworks (PXLW) | 2/1/2024 | 20.34% |
Celularity (CELU) | 2/1/2024 | 19.05% |
Lifestance Health (LFST) | 2/1/2024 | 18.74% |
RYTHM (RYM) | 2/1/2024 | 18.45% |
Apyx Medical (APYX) | 2/1/2024 | 18.1% |
SEALSQ (LAES) | 2/1/2024 | 17.68% |
Arcutis Biotherapeutics (ARQT) | 2/1/2024 | 17.52% |
Olema Pharmaceuticals (OLMA) | 2/1/2024 | 17.31% |
Sezzle (SEZL) | 2/1/2024 | 17.3% |
Xtant Medical (XTNT) | 2/1/2024 | 16.48% |
Nexalin Technology (NXL) | 2/1/2024 | 16.17% |